Strengths
Science 37 Metasite™ offers a unique virtual platform that eliminates physical barriers, allowing patients to participate in clinical trials from anywhere.
The company boasts a 100% population reach compared to traditional site-based trials, which typically reach less than 8%.
With a patient retention rate of 96%, Science 37 demonstrates a strong commitment to patient engagement and satisfaction.
The platform enables accelerated study start-up times, achieving single-day launches, which significantly enhances operational efficiency.
Science 37's diverse and experienced team of medical professionals ensures high-quality oversight and compliance throughout the trial process.
The Metasite™ model provides 3X greater diversity in patient recruitment compared to traditional methods, addressing critical gaps in clinical trial demographics.
The unified platform for compliance and data collection streamlines processes, reducing the risk of errors and improving data integrity.
The brand's positioning as a leader in decentralized clinical trials emphasizes innovation and inclusivity, appealing to a broad range of stakeholders.